The environment surrounding pharmaceutical companies is changing rapidly.
While interest in the advancement of innovative medical technology is growing due to the heightened awareness of people's health, expectations are rising for medical care that everyone can receive with peace of mind in a society where the birthrate is declining and the population is aging.
In Japan, while curbing the growth of soaring medical and drug costs, reforms to create a sustainable future are underway. In addition, many people in emerging countries, including the Asian region, are seeking safe and high-quality pharmaceuticals.
At Kokando Pharmaceutical, we place the utmost importance on creating high-quality,
heartfelt products that patients can use with peace of mind, based on solid
knowledge and experience.
We will contribute to people's health by always looking ahead of the times
and engaging in research and development with a young mind and taking on
new challenges.
Therefore, based on our management philosophy, we will actively invest in research and development, production facilities, and human resource development. Utilizing DX, we strive to develop and produce pharmaceuticals with excellent quality and safety for patients with high ethical and moral standards.
What is required of generic manufacturers.
These are stable supply, quality assurance, reliable information provision, and the expansion of generic drugs to the world.
With the advent of aging societies not only in developed countries but also in emerging countries, drug prices will be restrained, and the overseas market for generic drugs will grow significantly.
At Kokando Pharmaceutical, we promote efficiency through thorough quality control and strict manufacturing control, and provide patients with safe, high-quality products at affordable prices.
In addition to maintaining and improving the quality assurance system established based on the quality manual, we conduct thorough quality control at all stages, from raw materials to final products, with a high level of control awareness regarding the established manufacturing and quality standards.
At Kokando Pharmaceutical, we have introduced state-of-the-art manufacturing equipment to improve productivity, while promoting the computerization of manufacturing processes and the standardization of related human work to produce safe, high-quality products. I am producing.
we hope to be of service to people's health and lives by accurately grasping the wishes of people that never change and the new needs that arise with the times.
With ambition and passion, we strive to improve our technical capabilities with flexible thinking, and we will do our best to be of use to everyone.
In addition to the domestic market, we will also expand into overseas markets, mainly in Southeast Asia, with OTC drugs and generic drugs as our pillars.
We appreciate your continued understanding and support.
Company Name | Kokando Pharmaceutical Co., Ltd. |
---|---|
Established Date | February 1st, 1980 |
Locations | Head Office 2-8-27, Nagasuhondori, Amagasaki, Hyogo, Japan 660-0803 R&D Site 2-8-27, Nagasuhondori, Amagasaki, Hyogo, Japan 660-0803 Tokyo Office 1-7-1 Yurakucho, Chiyoda-ku, Tokyo, Japan 100-0006 Amagasaki plant 2-8-27, Nagasuhondori, Amagasaki, Hyogo, Japan 660-0803 Sanda plant 21-1 Techno-park, Sanda, Hyogo, Japan 669-1339 |
Chairman CEO |
FUJIWARA Kunio |
Capita l | 350 Million Yen |
Sales Proceeds | Sales 8595 Million Yen (for the year ended in June 2024) |
Business Outline | Manufacturing and Sales of Medicines |
Number of Employees | 233 (as of June 30, 2024) |
Affiliated Companies | Kokando Medicine Co., Ltd. Head office 1-1-1 Yurakucyo,Chiyoda-Ku,Tokyo,Japan 100-0006 Tokyo・Nagoya・Amagasaki |
1980 | Company founded |
---|---|
1981 | "REISHI", as health food containing activated |
1982 | Manufacturing site in Amagasaki completed |
1983 | Manufacturing and marketing of pharmaceutical drugs started |
1985 | Tokyo Office opened |
1986 | "SENNA Tablets" launched |
1989 | "NEO CALCIUM Tablets" launched |
1991 | "BEAULUCK", for constipation, launched |
1992 | "NATURAL VITAMIN E" and "VITAMIN C Tablets" launched |
1993 | The second manufacturing site in Amagasaki relocated (merged later) |
1994 | "VITAMIN BB" launched |
1996 | "KOKANDO BENPIYAKU", for constipation, and "NEO VITAMIN EX" launched |
1997 | The first manufacturing site in Amagasaki expanded and merged as Amagasaki Plant |
1998 | "VITAMIN EC-L Tablets" launched |
2000 | Nagoya Office opened "SOUGOUKANBOUYAKU", a cold remedy, launched |
2002 | "NEOVITA C Tablets" launched |
2003 | Several pharmaceutical drugs (analgesics etc.) launched "CONDRO POWER EX Tablets", for arthralgia, and "BIENYAKU", for Rhinitis, launched |
2007 | Manufacturing site in Sanda completed "NEOVITA WHITE PLUS" launched |
2008 | Head office relocated |
2009 | "NEW NEOVITAMIN EX", "VITAMIN BB PLUS" and "ADAM A Tablets", an antipyretic analgesic, launched |
2010 | "RIPOSMIN", for insomnia, launched |
2011 | "NORIMONOYOINOKUSURI", for motion sickness, launched |
2012 | "JIYOUKYOUSOUYAKU α", as health food for nourishment and tonicity, launched Tokyo Office relocated |
2013 | "FAMOTIDINE Tablets" lanched |
2014 | "LOXOPROFEN Tablets" lanched |
2016 | "ALLERBI" lanched |
2017 | "HEPAFIT" lanched |
2018 | "NEOVITA WHITE C PLUS" lanched |
2021 | "ACETAMINOPHEN Tablets" lanched |
2023 | "Shakuyakukanzoto Extract granules" lanched |
Head Office
Amagasaki plant
2-8-27, Nagasuhondori, Amagasaki, Hyogo, Japan 660-0803
Sanda plant
21-1 Techno-park, Sanda, Hyogo, Japan 669-1339